【レポートの概要（一部）】
1. Report Overview
1.1 The Molecular Diagnostics Market Overview
1.2 Molecular Diagnostics Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Reports
1.10 About Visiongain
2. Introduction to Molecular Diagnostics
2.1 What are In Vitro Diagnostic (IVD) Tests?
2.2 Classifying In Vitro Diagnostics
2.2.1 FDA Classifications
2.2.2 IVD Classification in Australia
2.2.3 The EC (European Commission) Classification
2.3 IVD Submarkets
2.3.1 Clinical Chemistry
2.3.2 Immunochemistry
2.3.3 Point-of-care Testing (Including Self-monitoring Blood Glucose Tests)
2.3.4 Molecular Diagnostics
2.3.4.1 Infectious Disease Testing
2.3.4.2 Oncology Testing
2.3.4.3 Blood Screening
2.3.4.4 Genetic Testing
2.3.4.5 Tissue Typing (HLA Testing)
2.3.5 Clinical Microbiology
2.3.6 Haematology/ Haemostasis
2.4 Regulation of the IVD and MDx Market
2.4.1 FDA and CLIA Regulation of IVD and MDx Tests
2.4.1.1 Regulation of IVD/MDx Tests in the EU: The EC (European Commission) Classification
2.4.2 Top Ten Challenges in Regulation for In-Vitro Diagnostics
2.4.2.1 Challenges in Regulations of MDx tests
2.5 Device Excise Tax: A Threat to the Diagnostics Manufacturers
3. The Molecular Diagnostics Segment Within the In Vitro Diagnostics Market, 2014-2024
3.1 Molecular Diagnostics in the IVD Market, 2013
3.2 Sales Forecast for the Global IVD Market 2014-2024
3.3 Molecular Diagnostics Gaining Greater Share of the IVD Market
4. The Molecular Diagnostics Market by Sectors, 2014-2024
4.1 The Molecular Diagnostic Market by Sectors, 2013
4.2 The Molecular Diagnostic Market by Sectors 2014-2024
4.2.1 Market Shares of the Molecular Diagnostics Sectors 2014-2024
4.3 The Infectious Disease Testing Market 2014-2024
4.3.1 Breakdown of the MDx Infectious Disease Testing Market by Disease, 2013
4.3.1.1 HPV Testing
4.3.1.2 CT/NT
4.3.1.3 HIV
4.3.1.4 Hepatitis C (HCV)
4.3.1.5 MRSA/ C. diff
4.4 The Oncology Testing Market, 2014-2024
4.4.1 Targeted Therapies: A Major Driver of the Oncology Testing Market
4.4.2 Molecular Diagnostics: Currently Concentrated on a Few Cancer Indications
4.4.2.1 Breast Cancer
4.4.2.2 Prostate Cancer
4.4.2.2.1 Pipeline Biomarker
4.4.2.2.1.1 TMPRSS2-ERG (OriGene)
4.4.2.2.1.2 PTEN
4.4.2.3 Colorectal Cancer
4.5 The Blood Screening Market 2014-2024
4.5.1 Grifols’ Acquisition of Novartis’s Blood Screening Unit
4.5.2 Leading Blood Screening Test Products
4.5.2.1 Cobas s 201 System (Roche Molecular)
4.5.2.2 Procleix Assays (Grifols)
4.6 The Genetic Testing Market 2014-2024
4.6.1 Genetic Testing by Clinical Impact Area
4.6.2 Genetic Testing: Potentially Many More Disease Indications
4.6.3 Cystic fibrosis
4.6.4 Factor V Leiden and Factor II Thrombophilia
4.6.5 Inflammatory diseases
4.6.5.1 Alzheimer’s Disease (AD)
4.6.5.2 Rheumatoid Arthritis
4.6.5.2.1 Vectra®DA (Crescendo Bioscience)
4.6.5.2.2 Quest Diagnostics: Biomarker Study
4.6.5.3 Rare Diseases
4.7 The Tissue Typing (HLA) Market 2014-2024
4.7.1 Tissue Typing: Next Generation Sequencing
5. The Leading Molecular Diagnostics National Markets, 2014-2024
5.1 Regional Breakdown of the Global MDx Market, 2013
5.2 The Global MDx Market Forecast 2014-2024
5.3 The Regional Market Shares of the MDx Market, 2014-2024
5.4 The US MDx Market 2013: Representing More than Half of the Global Market
5.4.1 The US MDx Market Forecast 2014-2024
5.4.1.1 United States: Diagnostic Reimbursement
5.5 The European MDx Markets Forecast, 2014-2024
5.5.1 Changes in the Shares of the Leading European Markets, 2014-2024
5.5.2 The German MDx Market Forecast 2014-2024
5.5.3 The French MDx Market Forecast 2014-2024
5.5.4 The Italian MDx Market Forecast 2014-2024
5.5.5 The Spanish MDx Market Forecast 2014-2024
5.5.6 The UK MDx Market Forecast 2014-2024
5.5.7 The Other European MDx Markets Forecast 2014-2024
5.6 The Japanese MDx Market Forecast 2014-2024
5.7 The Chinese MDx Market Forecast 2014-2024
5.7.1 China: Increasing Cancer Burden
5.8 The Brazilian MDx Market Forecast 2014-2024
5.9 The Russian MDx Market Forecast 2014-2024
5.10 The Indian MDx Market Forecast 2014-2024
5.10.1 India: Expansion of Healthcare Provisions
5.11 The South Korean MDx Market Forecast 2014-2024
5.12 The Mexican MDx Market Forecast 2014-2024
5.13 The Rest of the World Market Forecast 2014-2024
6. The Leading Companies in the Molecular Diagnostics Market, 2014-2024
6.1 Roche Diagnostics
6.1.1 Roche: Global Presence
6.1.2 Roche Diagnostics, 2014-2024
6.1.3 Roche Diagnostics Business Performance within the IVD Market, 2013
6.1.3.1 Molecular Diagnostics Sales Performance, 2013
6.1.3.2 Molecular Diagnostic Sales by Region, 2013
6.1.4 Roche Diagnostics: MDx Product Launches and Indication Expansion, 2014
6.1.4.1 Roche Diagnostics: Product Launch Plans, 2014
6.1.4.2 Roche: Recent M&A Activity and Strategic Partnerships
6.2 Hologic Gen-Probe
6.2.1 Hologic Recent Sales Performance by Business Segment, 2013
6.2.2 Hologic Molecular Diagnostics: Product Portfolio
6.2.3 Product Pipeline: Infectious Disease Focus, but Prostate Cancer Diagnostics Shows Promise
6.2.4 Changes in Molecular Diagnostic Operations Structuring
6.3 Qiagen
6.3.1 Sales and Recent Performance Analysis, 2013
6.3.2 Qiagen Sales by Region, 2013
6.3.3 Qiagen Sales by Segment, 2013
6.3.4 Qiagen: Molecular Diagnostics
6.3.5 Molecular Diagnostics: Product Expansion
6.3.5.1 QIASymphony
6.3.5.2 QuantiFERON-TB Gold: Expansion into China
6.3.5.3 Personalised Healthcare: Collaborative Efforts
6.3.5.4 Bioinformatics: Software Company Acquisitions
6.4 Becton, Dickinson & Company
6.4.1 Sales and Financial Performance, 2013
6.4.2 Sales and Financial Performance by Region, 2013
6.4.3 Becton Dickinson Diagnostics Sales and Financial Performance, 2012-2013
6.4.4 BD Diagnostics: Product Portfolio
6.4.5 BD Diagnostics: Mergers and Acquisitions
6.5 BioMérieux
6.5.1 Sales and Recent Performance Analysis, 2010-2013
6.5.2 Sales by Region, 2013
6.5.3 Sales by Technology, 2013
6.5.4 Molecular Diagnostics: Product Portfolio
6.5.5 Companion Diagnostics: Collaboration with GSK
6.5.6 Mergers and Acquisitions
6.5.7 bioTheranostics: Subsidiary for Oncology Diagnostics
6.6 Cepheid
6.6.1 Sales and Recent Performance Analysis, 2010-2013
6.6.2 Sales by Industry Segment, 2012-2013
6.6.3 Sales by Region, 2012-2013
6.6.4 Cepheid: Product Line
6.6.5 Cepheid: Business strategy
6.7 Agilent (Dako)
6.7.1 Sales and Recent Performance Analysis, 2013
6.7.2 Sales Performance by Business Segment, 2013
6.7.3 Agilent: Strong Player in Next Generation Sequencing
7. Qualitative Analysis of the MDx Market, 2014-2024
7.1 MDx market: Drivers and Restraints
7.2 SWOT Analysis of the MDx Market, 2014-2024
7.3 Strength
7.3.1 Patient Demographics
7.3.2 Increased Awareness
7.3.3 High Growth in Oncology Molecular Diagnostics
7.3.4 Increasing Laboratory Test Menus
7.3.5 Personalised Medicine: Optimising Treatment Outcomes
7.4 Weaknesses
7.4.1 Lack of Clear Regulatory Guidelines for Molecular Diagnostics
7.4.2 Reimbursement Challenges for Molecular Diagnostic Companies
7.4.2.1 Consolidation of Healthcare Systems Increases Pricing Pressure
7.4.2.2 Reimbursement Uncertainty Discourages Capital Investment
7.4.3 MDx: An Expensive, but Undervalued Diagnostic Tool
7.5 Opportunities
7.5.1 Next-generation Sequencing
7.5.2 Emerging Markets
7.5.3 The Emergence of New Microorganisms
7.6 Threats
7.6.1 US Medical Device Excise Tax
7.6.2 Gene Patents: Controversial Ruling
7.7 Porter’s Five Forces Analysis of the MDx Market
7.7.1 Rivalry Among Competitors [High]
7.7.2 Threat of New Entrants [Medium]
7.7.3 Power of Suppliers [Medium]
7.7.4 Power of Buyers [High]
7.7.5 Threat of Substitutes [High]
8. Expert Opinions
8.1 Mike Nugent, Worldwide Market Segment Leader BD MAX, BD Diagnostics
8.1.1 Becton Dickinson’s Leadership in Infectious Disease Molecular Diagnostics
8.1.2 BD MAX System: Becton Diagnostics Leading Product
8.1.3 The Changing Landscape of the MDx Industry
8.1.4 Cost: A Deterrent of MDx Use
9. Conclusions
9.1 The Molecular Diagnostics Market: Growing Market Share
9.2 Molecular Diagnostics: Oncology Testing Market Growth
9.3 Commercial Drivers of the Molecular Diagnostics Market
9.4 Commercial Restraints of the Molecular Diagnostics Market
9.5 Emerging Markets
9.6 Concluding Remarks
【レポート販売概要】
■ タイトル：世界の分子診断市場：感染症検査、癌検査、血液検査、遺伝子検査■ 英文：The Molecular Diagnostics (MDx) Market Forecast 2014-2024 : Opportunities for Leading Companies
■ 発行日：2014年10月
■ 調査会社：visiongain
■ 商品コード：VGAIN4120202
■ 調査対象地域：グローバル
- Mobile Devices and OS Comparative AnalysisDue to the rapid growth and evolution of the smart phone market, over the past few years, advances in network services drive the development of smart phones and drove the demand and popularity of smart phones. All smart phones come loaded with standard applications defined by the manufacturer. However, the network operators, looking for revenue opportunities, have encouraged the development of oth …
- Atrial Flutter：グローバル臨床試験レビューH1, 2013Atrial Flutter Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Atrial Flutter Global Clinical Trials Review, H1, 2013" provides data on the Atrial Flutter clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Atrial Flutter. It includes an overview of the trial numbers and their recruitment status as per …
- ビルディングインフォメーションモデル（BIM）の世界市場BIM refers to the development and use of computer-generated n-dimensional (n-D) models to simulate planning, design, construction, and operation of a facility. It is the next generation process in the construction industry, useful for designing buildings and managing the project data for crucial decisions to be taken. Building information modeling helps reduce costs, save time, and improve the spe …
- Offshore Wind Power – Global Market Size, Average Installation Price, Regulations, Market Share and Key Country Analysis to 2020Offshore Wind Power - Global Market Size, Average Installation Price, Regulations, Market Share and Key Country Analysis to 2020 Summary “Offshore Wind Power - Global Market Size, Average Installation Price, Regulations, Market Share and Key Country Analysis to 2020” is a key alternative energy report from GlobalData, that offer comprehensive information and understanding of the global offshore wi …
- Laboratoires Urgo S.A.：市場シェア分析Laboratoires Urgo S.A. Market Share Analysis Summary GlobalData’s new report, “Laboratoires Urgo S.A. Market Share Analysis” provides in-depth information on Laboratoires Urgo S.A.’s market position in the different medical equipment markets it operates in. The report provides Laboratoires Urgo S.A. market share information in four key market categories – Advanced Wound Management, Compression The …
- 世界のビックデータ市場：機会、課題、戦略、産業、予測“Big Data” originally emerged as a term to describe datasets whose size is beyond the ability of traditional databases to capture, store, manage and analyze. However, the scope of the term has significantly expanded over the years. Big Data not only refers to the data itself but also a set of technologies that capture, store, manage and analyze large and variable collections of data to solve compl …
- Yersinia：医療検査市場2014The report presents a detailed analysis of the Yersinia diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Yersinia definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commer …
- 血液検査の世界市場予測（～2021）：技術別（核酸増幅、（rPCR）、ELISA、（CLIA、蛍光アッセイ）、迅速試験、NGS、ウエスタンブロット）、製品別、需要先別Blood screening is a medical process in which donated blood is mainly tested for HIV1, HIV2, HBV, HCV, malaria, syphilis, and various other infectious diseases. Donated blood is screened for these infectious diseases to reduce the risk of transfusion-transmitted infections (TTIs). The global blood screening market consists of various technologies and products & services which are used in blood ban …
- 車両接近通報装置（AVAS）の世界市場予測（～2027年）“Government mandate for implementation of acoustic vehicle alerting system is significant factors for the growth of the acoustic vehicle alerting system market globally”The acoustic vehicle alerting system market is projected to reach USD 5,615 million by 2027 from an estimated USD 425 million in 2019 considering the installation of AVAS in passenger car and commercial vehicle, at a CAGR of 38.1% …
- スマートバンドの世界市場2016-2020Technavio’s research analyst predicts the global smart band market to grow steadily at a CAGR of around 8% during the forecast period. The high demand for wearable lifestyle devices is the key growth driver for this market. Consumers use smartwatches, smart bands, and wearable rings to monitor daily fitness and health activities, listen to music, check virtual/3D videos, play virtual games, and ac …
- 世界の有機金属気相成長法（MOCVD）市場動向（2012-2016）TechNavio's analysts forecast Global Metal Organic Chemical Vapor Deposition market to grow at a CAGR of 18.6 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for LEDs in the lighting applications. Global Metal Organic Chemical Vapor Deposition market has also been witnessing a gradual shift to six-inch wafers and sapphire substr …
- ラップトップ（ノートパソコン）の世界市場2015-2019About Laptop Laptops are believed to be facing a sort of identity crisis, as a variety of equivalent products with myriad names, like notebook, life book, etc. is spanning the global computers market. The many theories of possible health hazards related to keeping the machine on the lap for long hours, have led to manufacturers come up with different products in the name of like notebook, air book …
- ブラジルの化粧品市場2015-2019Technavios research analyst predicts the cosmetics market in Brazil to grow at a CAGR of 11% during the forecast period. The increase in the number of working women is the primary driver for the growth of this market. The need to look fresh and presentable at the workplace is the key reason for the increase in expenditure on cosmetics by working women. Moreover, women in Brazil are now more inform …
- パーソナルケア製品用成分の世界市場：界面活性剤、コンディショニング・ポリマー、皮膚軟化剤、レオロジー改質剤The personal care ingredients market is projected to register a CAGR of 5.4% between 2015 and 2020 to reach $17,600.0 million. The market for personal care ingredients is estimated to grow on account of changing lifestyle and increase in spending capacity. Huge demand from Asia-Pacific region and increasing demand for multi-functional ingredients are also major driving factors driving the personal …
- 通信費用管理（Telecom Expense Management）ソリューションの世界市場The Telecom Expense Management (TEM) market in this report is defined as the process or tool that is employed by enterprises to control their wireless, wireline, mobile, and data assets. The TEM market is segmented into traditional solutions, service delivery modes, end users, verticals, and regions. The solutions include sourcing management, reporting and business management, dispute management, …
